These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 29698802

  • 21. Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma.
    Papale M, Vocino G, Lucarelli G, Rutigliano M, Gigante M, Rocchetti MT, Pesce F, Sanguedolce F, Bufo P, Battaglia M, Stallone G, Grandaliano G, Carrieri G, Gesualdo L, Ranieri E.
    Oncotarget; 2017 Jun 20; 8(25):40412-40424. PubMed ID: 28418894
    [Abstract] [Full Text] [Related]

  • 22. Percentage grade 4 tumour predicts outcome for clear cell renal cell carcinoma.
    Dagher J, Delahunt B, Rioux-Leclercq N, Egevad L, Varma M, Samaratunga H.
    Pathology; 2019 Jun 20; 51(4):349-352. PubMed ID: 30987774
    [Abstract] [Full Text] [Related]

  • 23. Detecting Proteomic Indicators to Distinguish Diabetic Nephropathy from Hypertensive Nephrosclerosis by Integrating Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging with High-Mass Accuracy Mass Spectrometry.
    Smith A, Iablokov V, Mazza M, Guarnerio S, Denti V, Ivanova M, Stella M, Piga I, Chinello C, Heijs B, van Veelen PA, Benediktsson H, Muruve DA, Magni F.
    Kidney Blood Press Res; 2020 Jun 20; 45(2):233-248. PubMed ID: 32062660
    [Abstract] [Full Text] [Related]

  • 24. Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma.
    Du Y, Wang Q, Zhang X, Wang X, Qin C, Sheng Z, Yin H, Jiang C, Li J, Xu T.
    J Exp Clin Cancer Res; 2017 May 12; 36(1):66. PubMed ID: 28494778
    [Abstract] [Full Text] [Related]

  • 25. iTRAQ-based quantitative proteomic analysis reveals potential early diagnostic markers of clear-cell Renal cell carcinoma.
    Zhang L, Jiang H, Xu G, Chu N, Xu N, Wen H, Gu B, Liu J, Mao S, Na R, Jing Y, Ding Q, Zhang Y, Wang L.
    Biosci Trends; 2016 Jul 19; 10(3):210-9. PubMed ID: 27319973
    [Abstract] [Full Text] [Related]

  • 26. Searching for prognostic biomarkers for small renal masses in the urinary proteome.
    Di Meo A, Batruch I, Brown MD, Yang C, Finelli A, Jewett MA, Diamandis EP, Yousef GM.
    Int J Cancer; 2020 Apr 15; 146(8):2315-2325. PubMed ID: 31465112
    [Abstract] [Full Text] [Related]

  • 27. Cytoplasmic expression of Twist1, an EMT-related transcription factor, is associated with higher grades renal cell carcinomas and worse progression-free survival in clear cell renal cell carcinoma.
    Rasti A, Madjd Z, Abolhasani M, Mehrazma M, Janani L, Saeednejad Zanjani L, Asgari M.
    Clin Exp Med; 2018 May 15; 18(2):177-190. PubMed ID: 29204790
    [Abstract] [Full Text] [Related]

  • 28. Assessment of tumour-associated necrosis provides prognostic information additional to World Health Organization/International Society of Urological Pathology grading for clear cell renal cell carcinoma.
    Dagher J, Delahunt B, Rioux-Leclercq N, Egevad L, Coughlin G, Dunglison N, Gianduzzo T, Kua B, Malone G, Martin B, Preston J, Pokorny M, Wood S, Samaratunga H.
    Histopathology; 2019 Jan 15; 74(2):284-290. PubMed ID: 30129659
    [Abstract] [Full Text] [Related]

  • 29. Label-free quantitative proteomic analysis reveals potential biomarkers and pathways in renal cell carcinoma.
    Zhao Z, Wu F, Ding S, Sun L, Liu Z, Ding K, Lu J.
    Tumour Biol; 2015 Feb 15; 36(2):939-51. PubMed ID: 25315187
    [Abstract] [Full Text] [Related]

  • 30. MALDI Orbitrap Mass Spectrometry Profiling of Dysregulated Sulfoglycosphingolipids in Renal Cell Carcinoma Tissues.
    Jirásko R, Holčapek M, Khalikova M, Vrána D, Študent V, Prouzová Z, Melichar B.
    J Am Soc Mass Spectrom; 2017 Aug 15; 28(8):1562-1574. PubMed ID: 28361385
    [Abstract] [Full Text] [Related]

  • 31. Pathway analysis of kidney cancer using proteomics and metabolic profiling.
    Perroud B, Lee J, Valkova N, Dhirapong A, Lin PY, Fiehn O, Kültz D, Weiss RH.
    Mol Cancer; 2006 Nov 24; 5():64. PubMed ID: 17123452
    [Abstract] [Full Text] [Related]

  • 32. MALDI imaging on tissue microarrays identifies molecular features associated with renal cell cancer phenotype.
    Steurer S, Seddiqi AS, Singer JM, Bahar AS, Eichelberg C, Rink M, Dahlem R, Huland H, Sauter G, Simon R, Minner S, Burandt E, Stahl PR, Schlomm T, Wurlitzer M, Schlüter H.
    Anticancer Res; 2014 May 24; 34(5):2255-61. PubMed ID: 24778028
    [Abstract] [Full Text] [Related]

  • 33. Identification of cyclophilin A as a potential prognostic factor for clear-cell renal cell carcinoma by comparative proteomic analysis.
    Yang J, Li A, Yang Y, Li X.
    Cancer Biol Ther; 2011 Mar 01; 11(5):535-46. PubMed ID: 21368578
    [Abstract] [Full Text] [Related]

  • 34. Predominantly cystic clear cell renal cell carcinoma and multilocular cystic renal neoplasm of low malignant potential form a low-grade spectrum.
    Tretiakova M, Mehta V, Kocherginsky M, Minor A, Shen SS, Sirintrapun SJ, Yao JL, Alvarado-Cabrero I, Antic T, Eggener SE, Picken MM, Paner GP.
    Virchows Arch; 2018 Jul 01; 473(1):85-93. PubMed ID: 29770853
    [Abstract] [Full Text] [Related]

  • 35. Use of tryptic peptide MALDI mass spectrometry imaging to identify the spatial proteomic landscape of colorectal cancer liver metastases.
    Li CMY, Briggs MT, Lee YR, Tin T, Young C, Pierides J, Kaur G, Drew P, Maddern GJ, Hoffmann P, Klingler-Hoffmann M, Fenix K.
    Clin Exp Med; 2024 Mar 16; 24(1):53. PubMed ID: 38492056
    [Abstract] [Full Text] [Related]

  • 36. Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging: Diagnostic Pathways and Metabolites for Renal Tumor Entities.
    Erlmeier F, Sun N, Shen J, Feuchtinger A, Buck A, Prade VM, Kunzke T, Schraml P, Moch H, Autenrieth M, Weichert W, Hartmann A, Walch A.
    Oncology; 2023 Mar 16; 101(2):126-133. PubMed ID: 36198279
    [Abstract] [Full Text] [Related]

  • 37. Transcriptome-proteome integration of archival human renal cell carcinoma biopsies enables identification of molecular mechanisms.
    Koch E, Finne K, Eikrem Ø, Landolt L, Beisland C, Leh S, Delaleu N, Granly M, Vikse BE, Osman T, Scherer A, Marti HP.
    Am J Physiol Renal Physiol; 2019 May 01; 316(5):F1053-F1067. PubMed ID: 30838877
    [Abstract] [Full Text] [Related]

  • 38. The highest Fuhrman and WHO/ISUP grade influences the Ki-67 labeling index of those of grades 1 and 2 in clear cell renal cell carcinoma.
    Murase Y, Iwata H, Takahara T, Tsuzuki T.
    Pathol Int; 2020 Dec 01; 70(12):984-991. PubMed ID: 32997867
    [Abstract] [Full Text] [Related]

  • 39. Ambient ionization mass spectrometric analysis of human surgical specimens to distinguish renal cell carcinoma from healthy renal tissue.
    Alfaro CM, Jarmusch AK, Pirro V, Kerian KS, Masterson TA, Cheng L, Cooks RG.
    Anal Bioanal Chem; 2016 Aug 01; 408(20):5407-14. PubMed ID: 27206411
    [Abstract] [Full Text] [Related]

  • 40. Automated clear cell renal carcinoma grade classification with prognostic significance.
    Tian K, Rubadue CA, Lin DI, Veta M, Pyle ME, Irshad H, Heng YJ.
    PLoS One; 2019 Aug 01; 14(10):e0222641. PubMed ID: 31581201
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.